210 related articles for article (PubMed ID: 19514130)
1. Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centers.
Lötsch J; von Hentig N; Freynhagen R; Griessinger N; Zimmermann M; Doehring A; Rohrbacher M; Sittl R; Geisslinger G
Pharmacogenet Genomics; 2009 Jun; 19(6):429-36. PubMed ID: 19514130
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects.
Rhodin A; Grönbladh A; Ginya H; Nilsson KW; Rosenblad A; Zhou Q; Enlund M; Hallberg M; Gordh T; Nyberg F
Mol Brain; 2013 Feb; 6():8. PubMed ID: 23402298
[TBL] [Abstract][Full Text] [Related]
3. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
[TBL] [Abstract][Full Text] [Related]
4. Effects of genetic polymorphisms of OPRM1, ABCB1, CYP3A4/5 on postoperative fentanyl consumption in Korean gynecologic patients.
Kim KM; Kim HS; Lim SH; Cheong SH; Choi EJ; Kang H; Choi HR; Jeon JW; Yon JH; Oh M; Shin JG
Int J Clin Pharmacol Ther; 2013 May; 51(5):383-92. PubMed ID: 23557865
[TBL] [Abstract][Full Text] [Related]
5. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
[TBL] [Abstract][Full Text] [Related]
6.
Firfirey F; September AV; Shamley D
Pharmacogenomics; 2022 Jun; 23(9):513-530. PubMed ID: 35727214
[No Abstract] [Full Text] [Related]
7. Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study.
Aubrun F; Zahr N; Langeron O; Boccheciampe N; Cozic N; Belin L; Hulot JS; Khiami F; Riou B
Eur J Anaesthesiol; 2018 Jul; 35(7):496-504. PubMed ID: 29474345
[TBL] [Abstract][Full Text] [Related]
8. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment.
Walter C; Lötsch J
Pain; 2009 Dec; 146(3):270-275. PubMed ID: 19683391
[TBL] [Abstract][Full Text] [Related]
10. Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome.
Wachman EM; Hayes MJ; Brown MS; Paul J; Harvey-Wilkes K; Terrin N; Huggins GS; Aranda JV; Davis JM
JAMA; 2013 May; 309(17):1821-7. PubMed ID: 23632726
[TBL] [Abstract][Full Text] [Related]
11. Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief.
Campa D; Gioia A; Tomei A; Poli P; Barale R
Clin Pharmacol Ther; 2008 Apr; 83(4):559-66. PubMed ID: 17898703
[TBL] [Abstract][Full Text] [Related]
12. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
13. Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study.
Beer B; Erb R; Pavlic M; Ulmer H; Giacomuzzi S; Riemer Y; Oberacher H
PLoS One; 2013; 8(9):e75359. PubMed ID: 24086514
[TBL] [Abstract][Full Text] [Related]
14. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
15. OPRM1 and ABCB1 polymorphisms and their effect on postoperative pain relief with piritramide.
Bartošová O; Polanecký O; Perlík F; Adámek S; Slanař O
Physiol Res; 2015; 64(Suppl 4):S521-7. PubMed ID: 26681082
[TBL] [Abstract][Full Text] [Related]
16. Effects of
Zhao Z; Lv B; Zhao X; Zhang Y
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30455395
[TBL] [Abstract][Full Text] [Related]
17. Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers.
McLaughlin P; Mactier H; Gillis C; Hickish T; Parker A; Liang WJ; Osselton MD
J Pediatr; 2017 Nov; 190():180-184.e1. PubMed ID: 28867064
[TBL] [Abstract][Full Text] [Related]
18. Pilot study examining the frequency of several gene polymorphisms involved in morphine pharmacodynamics and pharmacokinetics in a morbidly obese population.
Lloret Linares C; Hajj A; Poitou C; Simoneau G; Clement K; Laplanche JL; Lépine JP; Bergmann JF; Mouly S; Peoc'h K
Obes Surg; 2011 Aug; 21(8):1257-64. PubMed ID: 20411349
[TBL] [Abstract][Full Text] [Related]
19. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene.
Reyes-Gibby CC; Shete S; Rakvåg T; Bhat SV; Skorpen F; Bruera E; Kaasa S; Klepstad P
Pain; 2007 Jul; 130(1-2):25-30. PubMed ID: 17156920
[TBL] [Abstract][Full Text] [Related]
20. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
